Financials
Financial year 2025
ONCOLUX from Meix-devant-Virton, company number BE0474615654, closed financial year 2025 with a result of € 80,253 after tax. For that financial year ONCOLUX recorded a gross margin of € 121,811 and equity of € 408,128. Compared with financial year 2024, the result moved from € 91,608 to € 80,253. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 408,128
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 80,253
▼ 12% vs 2024
Profit after tax over the fiscal year.
€ 99,046
▼ 22% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 35,497 paid out
44 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 41,763
▲ € 40,223 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8,247
▲ 127% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 500
▼ 94% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 97,513 | € 156,941 | € 129,489 | € 121,811 | ▼ 6% |
| Profit after taxes | € 63,999 | € 99,439 | € 91,608 | € 80,253 | ▼ 12% |
| Equity | € 348,427 | € 306,305 | € 363,372 | € 408,128 | ▲ 12% |
| Total debts | € 19,527 | € 17,706 | € 18,730 | € 14,671 | ▼ 22% |
| Cash | € 303,971 | € 92,602 | € 127,711 | € 99,046 | ▼ 22% |
| Retained profit | € 336,027 | € 306,305 | € 363,372 | € 408,128 | ▲ 12% |
| Dividend | € 1,600 | € 129,160 | € 34,541 | € 35,497 | ▲ 3% |
| Balance sheet total | € 372,189 | € 330,364 | € 382,101 | € 422,800 | ▲ 11% |
Key figures of ONCOLUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ONCOLUX?
What happened at ONCOLUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 80,253 (▼ 12% vs 2024). Source: NBB ↗
- Philippe GLORIEUX became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 63,999 profit in 2022 to € 80,253 profit in 2025.
Paid € 154,934 in corporate taxes since 2022.
Best year ever: 2023, with € 99,439 profit.
Paid out € 200,798 in dividends to the owners in total.
Management
Behind ONCOLUX is Philippe GLORIEUX.
Directors
According to the 2025 annual accounts
Philippe GLORIEUX
Director
since 2023
Establishments
Establishment units
Physical locations of this company
Chemin des Naux,Robelmont 15
6769 Meix-devant-Virton
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0474.615.654
- VAT number
- BE 0474.615.654
- Registered office
- Chemin des Naux,Robelmont 15, 6769 Meix-devant-Virton
- Names & denominations
- ONCOLUX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 April 2001
- Peppol
- Active · Active since 9 Feb 2026
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering